Cargando…
Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients
BACKGROUND: Surgical risk prediction models are routinely used to guide decision-making for transcatheter aortic valve replacement (TAVR). New and updated TAVR-specific models have been developed to improve risk stratification; however, the best option remains unknown. OBJECTIVE: To perform a compar...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907023/ https://www.ncbi.nlm.nih.gov/pubmed/32851491 http://dx.doi.org/10.1007/s00392-020-01731-9 |
_version_ | 1783655408929341440 |
---|---|
author | Wolff, Georg Shamekhi, Jasmin Al-Kassou, Baravan Tabata, Noriaki Parco, Claudio Klein, Kathrin Maier, Oliver Sedaghat, Alexander Polzin, Amin Sugiura, Atsushi Jung, Christian Grube, Eberhard Westenfeld, Ralf Icks, Andrea Zeus, Tobias Sinning, Jan-Malte Baldus, Stephan Nickenig, Georg Kelm, Malte Veulemans, Verena |
author_facet | Wolff, Georg Shamekhi, Jasmin Al-Kassou, Baravan Tabata, Noriaki Parco, Claudio Klein, Kathrin Maier, Oliver Sedaghat, Alexander Polzin, Amin Sugiura, Atsushi Jung, Christian Grube, Eberhard Westenfeld, Ralf Icks, Andrea Zeus, Tobias Sinning, Jan-Malte Baldus, Stephan Nickenig, Georg Kelm, Malte Veulemans, Verena |
author_sort | Wolff, Georg |
collection | PubMed |
description | BACKGROUND: Surgical risk prediction models are routinely used to guide decision-making for transcatheter aortic valve replacement (TAVR). New and updated TAVR-specific models have been developed to improve risk stratification; however, the best option remains unknown. OBJECTIVE: To perform a comparative validation study of six risk models for the prediction of 30-day mortality in TAVR METHODS AND RESULTS: A total of 2946 patients undergoing transfemoral (TF, n = 2625) or transapical (TA, n = 321) TAVR from 2008 to 2018 from the German Rhine Transregio Aortic Diseases cohort were included. Six surgical and TAVR-specific risk scoring models (LogES I, ES II, STS PROM, FRANCE-2, OBSERVANT, GAVS-II) were evaluated for the prediction of 30-day mortality. Observed 30-day mortality was 3.7% (TF 3.2%; TA 7.5%), mean 30-day mortality risk prediction varied from 5.8 ± 5.0% (OBSERVANT) to 23.4 ± 15.9% (LogES I). Discrimination performance (ROC analysis, c-indices) ranged from 0.60 (OBSERVANT) to 0.67 (STS PROM), without significant differences between models, between TF or TA approach or over time. STS PROM discriminated numerically best in TF TAVR (c-index 0.66; range of c-indices 0.60 to 0.66); performance was very similar in TA TAVR (LogES I, ES II, FRANCE-2 and GAVS-II all with c-index 0.67). Regarding calibration, all risk scoring models—especially LogES I—overestimated mortality risk, especially in high-risk patients. CONCLUSIONS: Surgical as well as TAVR-specific risk scoring models showed mediocre performance in prediction of 30-day mortality risk for TAVR in the German Rhine Transregio Aortic Diseases cohort. Development of new or updated risk models is necessary to improve risk stratification. GRAPHIC ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00392-020-01731-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7907023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-79070232021-03-09 Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients Wolff, Georg Shamekhi, Jasmin Al-Kassou, Baravan Tabata, Noriaki Parco, Claudio Klein, Kathrin Maier, Oliver Sedaghat, Alexander Polzin, Amin Sugiura, Atsushi Jung, Christian Grube, Eberhard Westenfeld, Ralf Icks, Andrea Zeus, Tobias Sinning, Jan-Malte Baldus, Stephan Nickenig, Georg Kelm, Malte Veulemans, Verena Clin Res Cardiol Original Paper BACKGROUND: Surgical risk prediction models are routinely used to guide decision-making for transcatheter aortic valve replacement (TAVR). New and updated TAVR-specific models have been developed to improve risk stratification; however, the best option remains unknown. OBJECTIVE: To perform a comparative validation study of six risk models for the prediction of 30-day mortality in TAVR METHODS AND RESULTS: A total of 2946 patients undergoing transfemoral (TF, n = 2625) or transapical (TA, n = 321) TAVR from 2008 to 2018 from the German Rhine Transregio Aortic Diseases cohort were included. Six surgical and TAVR-specific risk scoring models (LogES I, ES II, STS PROM, FRANCE-2, OBSERVANT, GAVS-II) were evaluated for the prediction of 30-day mortality. Observed 30-day mortality was 3.7% (TF 3.2%; TA 7.5%), mean 30-day mortality risk prediction varied from 5.8 ± 5.0% (OBSERVANT) to 23.4 ± 15.9% (LogES I). Discrimination performance (ROC analysis, c-indices) ranged from 0.60 (OBSERVANT) to 0.67 (STS PROM), without significant differences between models, between TF or TA approach or over time. STS PROM discriminated numerically best in TF TAVR (c-index 0.66; range of c-indices 0.60 to 0.66); performance was very similar in TA TAVR (LogES I, ES II, FRANCE-2 and GAVS-II all with c-index 0.67). Regarding calibration, all risk scoring models—especially LogES I—overestimated mortality risk, especially in high-risk patients. CONCLUSIONS: Surgical as well as TAVR-specific risk scoring models showed mediocre performance in prediction of 30-day mortality risk for TAVR in the German Rhine Transregio Aortic Diseases cohort. Development of new or updated risk models is necessary to improve risk stratification. GRAPHIC ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00392-020-01731-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-08-26 2021 /pmc/articles/PMC7907023/ /pubmed/32851491 http://dx.doi.org/10.1007/s00392-020-01731-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Paper Wolff, Georg Shamekhi, Jasmin Al-Kassou, Baravan Tabata, Noriaki Parco, Claudio Klein, Kathrin Maier, Oliver Sedaghat, Alexander Polzin, Amin Sugiura, Atsushi Jung, Christian Grube, Eberhard Westenfeld, Ralf Icks, Andrea Zeus, Tobias Sinning, Jan-Malte Baldus, Stephan Nickenig, Georg Kelm, Malte Veulemans, Verena Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients |
title | Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients |
title_full | Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients |
title_fullStr | Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients |
title_full_unstemmed | Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients |
title_short | Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients |
title_sort | risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 german patients |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907023/ https://www.ncbi.nlm.nih.gov/pubmed/32851491 http://dx.doi.org/10.1007/s00392-020-01731-9 |
work_keys_str_mv | AT wolffgeorg riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT shamekhijasmin riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT alkassoubaravan riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT tabatanoriaki riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT parcoclaudio riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT kleinkathrin riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT maieroliver riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT sedaghatalexander riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT polzinamin riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT sugiuraatsushi riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT jungchristian riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT grubeeberhard riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT westenfeldralf riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT icksandrea riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT zeustobias riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT sinningjanmalte riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT baldusstephan riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT nickeniggeorg riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT kelmmalte riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients AT veulemansverena riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients |